Position in BMY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$243,156
-$147,369 QoQ
Shares Held
4,220
-34.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,012
of 2,506 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Core Wealth Partners LLC holds $9,914,904 across 8 Drug Manufacturers - General names. BMY ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
11,580 | $2,940,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
18,313 | $2,313,664 | |
| 3 | ABBV |
AbbVie Inc.
|
6,948 | $1,748,394 | |
| 4 | LLY |
ELI LILLY & Co
|
1,132 | $1,357,754 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,447 | $828,439 | |
| 6 | PFE |
Pfizer Inc
|
11,587 | $279,014 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,220 | $243,156 | |
| 8 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $243,156 | 4,220 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $390,525 | 6,439 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $346,564 | 6,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $235,422 | 5,220 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $241,633 | 5,220 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $344,288 | 5,645 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $317,867 | 5,620 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $235,417 | 4,550 | Shares | Sole | 2024-11-04 | |
| 2022-12-31 | $180,378 | 2,507 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||